NaCl 0,9% ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

53. シェーグレン症候群

---

臨床試験数 : 283 /  薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03700138 (ClinicalTrials.gov)	June 19, 2019	24/8/2018	Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies	Prospective, Randomised, Placebo-controlled Study of Polyvalent Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies	Primary Sjögren's Syndrome Painful Sensory Neuropathies	Drug: Privigen® 100mg/ml at the dose of 2g/kg of body weight;Drug: NaCl 0,9%	University Hospital, Strasbourg, France	NULL	Recruiting	18 Years	80 Years	All	24	Phase 3	France